Montpellier, France

Cindy Patinote


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Spotlight on Inventor Cindy Patinote: A Pioneer in Cancer Research

Introduction: Cindy Patinote, an innovative inventor based in Montpellier, France, has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. With a passion for research and development, her pioneering efforts have led to the creation of a notable patent that showcases her commitment to advancing medical science.

Latest Patents: Cindy Patinote holds a patent for "Imidazo[1,2-a]quinoxalines and derivatives thereof for the treatment of cancer." This invention pertains to specific imidazo[1,2-a]quinoxaline compounds and their applications in pharmaceutical compositions aimed at combating cancer. The therapeutic uses of these compounds mark an important development in cancer treatment options.

Career Highlights: Throughout her career, Patinote has been associated with prestigious institutions such as the Université de Montpellier and the Centre National de la Recherche Scientifique. Her work at these institutions has not only refined her expertise but has also contributed to her innovative thinking in pharmaceutical sciences.

Collaborations: Cindy has collaborated with several esteemed colleagues, including Carine Deleuze-Masquefa and Pierre-Antoine Bonnet. These partnerships have fostered a collaborative research environment that encourages the exchange of ideas and advancements in cancer research.

Conclusion: Cindy Patinote stands out as a remarkable inventor whose work focuses on innovative cancer treatments. Her contributions underscore the importance of research-oriented careers in combating one of the most pressing health challenges of our time. As her patents and collaborative efforts continue to influence the pharmaceutical landscape, Cindy remains a prominent figure within the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…